Karun D. Naga is an operating executive and entrepreneur in the healthcare industry. As part of The Foundry’s leadership, Karun led the formation of and incubation effort behind Foundry Therapeutics, a new venture focused on the development of combination products for localized, sustained administration of therapeutic agents, and served as founding CEO for Foundry Therapeutics 1, a clinical stage company focused on durable pain control following major surgery.

Prior to joining The Foundry, Karun was part of the executive team at Altura Medical, a venture funded startup that developed a breakthrough endograft for treating abdominal aortic aneurysm and was acquired by Lombard Medical. Prior to joining Altura Medical, Karun was Director of Corporate Development at Medtronic, where he had roles in business development, strategic partnering and corporate investment across Medtronic’s cardiovascular portfolio. Karun joined Medtronic via its acquisition of Ardian, a Foundry portfolio company that pioneered a catheter-based treatment for hypertension, where he served on its executive management team. In a previous stint with The Foundry, Karun served on the founding team of Miramar Labs, a dermatology and aesthetics medicine company. Karun also previously worked at Mentor Corporation, as its first in-house intellectual property counsel, and Jones Day, a leading international law firm.

Karun holds a BS in mechanical engineering from Michigan State University, a JD from the University of Michigan Law School and an MBA from The Wharton School of The University of Pennsylvania.